Immune Globulin Intravenous

intravenous immunoglobulin · Grifols Therapeutics LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immune Globulin Intravenous, covering 2014-04-11 to 2014-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis [Phase 2]